http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21485772

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article
endingPage 813
issn 1432-0843
0344-5704
issueIdentifier 3
pageRange 805-813
publicationName Cancer Chemotherapy and Pharmacology
startingPage 805
bibliographicCitation Hamberg P, Woo MM, Chen L, Verweij J, Porro MG, Zhao L, Li W, van der Biessen D, Sharma S, Hengelage T, de Jonge M. Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor. Cancer Chemotherapy and Pharmacology. 2011 Jun 26;68(3):805–13. doi: 10.1007/s00280-011-1693-x.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d239b58c7919f2a6ce04a826d34302a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4379bb4cf6398fceffc34bf265cfab3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92b588e97d9164d1996a7e2c2b7dac65
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_822bdc2cb5208e16002547b854460e9c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32ae419e6cd7cd31250bffe8f46693f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_129f15f871c92621dd893403259e9cd2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f8b1c947b50fcb9a80f6b1ddf558580
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d89216edd4829d37875a560e1200a4d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e74335ab708b5b8d29ed01d3de1256b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d38f038f3638349cf3f4471f4c75fbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37c6b9851d4addaa8b8189fe68c5d5e5
date 2011-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3162150
https://pubmed.ncbi.nlm.nih.gov/21706316
https://doi.org/10.1007/s00280-011-1693-x
isPartOf https://portal.issn.org/resource/ISSN/0344-5704
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664
https://portal.issn.org/resource/ISSN/1432-0843
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor
discusses http://id.nlm.nih.gov/mesh/M0540392
http://id.nlm.nih.gov/mesh/M0010739
http://id.nlm.nih.gov/mesh/M0011238
http://id.nlm.nih.gov/mesh/M0011987
http://id.nlm.nih.gov/mesh/M0590383
http://id.nlm.nih.gov/mesh/M0527853
http://id.nlm.nih.gov/mesh/M0082919
http://id.nlm.nih.gov/mesh/M0159612
http://id.nlm.nih.gov/mesh/M0001399
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.98
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73951506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918837
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8535dce74a282d4ae5610eb102d132e9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129571406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129826180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129185848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248745162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128194857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247360797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128447465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129071275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129552408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129708236

Total number of triples: 64.